Decreasing incidence of coronary heart disease in extreme obesity (BMI≥40)-A single centre experience

Sebastian Barth1, Michael Zacher2, Holger Reinecke3

  • 1Department of Cardiology, Cardiovascular Center Bad Neustadt, Salzburger Leite 1, 97616 Bad Neustadt, Germany.

Insights

Extremely obese patients showed a lower incidence of coronary heart disease (CHD) but higher mortality. This study highlights the complex relationship between obesity, CHD, and patient outcomes.

Area of Science:

  • Cardiology
  • Obesity Medicine
  • Public Health

Background:

  • Coronary heart disease (CHD) is a significant health concern, particularly in obese populations.
  • Understanding the incidence and outcomes of CHD in extremely obese individuals is crucial for effective clinical management.

Purpose of the Study:

  • To evaluate the incidence of coronary heart disease (CHD) in extremely obese patients.
  • To analyze cardiovascular risk factors, comorbidities, and mortality rates in different weight classes.

Main Methods:

  • Retrospective analysis of 23,359 patients undergoing cardiac catheterisation between 2005 and 2015.
  • Patients categorized into six weight classes based on World Health Organization (WHO) criteria.
  • Multivariable analysis to determine odds ratios for CHD and mortality.

Main Results:

  • Older age, male sex, cardiovascular risk factors, atherosclerosis, and angina were associated with increased odds of CHD.
  • NYHA functional class I-IV, absence of angina, and BMI ≥40 were associated with decreased odds of CHD.
  • Extremely obese patients had lower CHD incidence (38.6%) compared to normal weight individuals (46.1%), but higher all-cause in-hospital mortality (1.6% vs. 5.3% in underweight).

Conclusions:

  • Despite a surprisingly decreased incidence of CHD in severely obese patients, their associated comorbidities led to higher all-cause in-hospital mortality.
  • Obesity presents a complex interplay with CHD, necessitating tailored management strategies.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
798
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
562
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.9K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
873